Loading clinical trials...
Loading clinical trials...
ADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rohto Pharmaceutical Co., Ltd.
NCT05365282 · Ischemic Heart Disease, Nerve Injury, and more
NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease
NCT06631157 · Coronary Artery Disease, Ischemic Heart Disease
NCT05682118 · Ischemic Heart Disease
NCT05788432 · Coronary Artery Disease, Ischemic Heart Disease
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions